We recently showed that central injections of -melanocyte-stimulating hormone ( -MSH) inhibits oxytocin cells and reduces peripheral release of oxytocin, but induces oxytocin release from dendrites. Dendritic oxytocin release can be triggered by agents that mobilize intracellular calcium. Oxytocin, like -MSH, mobilises intracellular calcium stores in oxytocin cells, and triggers presynaptic inhibition of afferent inputs that is mediated by cannabinoids, and we hypothesized that this mechanism might underlie the inhibitory effects of -MSH. To test this, we recorded extracellularly from identified oxytocin and vasopressin cells in the anesthetised rat SON. 
INTRODUCTION
The supraoptic nucleus (SON) contains magnocellular neurons that project to the posterior pituitary where they secrete oxytocin and vasopressin into the circulation. Vasopressin and oxytocin are also released centrally, and are involved in several behaviours (47) ; central release originates in part from parvocellular neurons of the paraventricular nucleus (PVN), but both peptides are also released from the dendrites of magnocellular neurons of the PVN and SON (20) . Dendritically released oxytocin has autoregulatory actions on SON neurons; notably, these include facilitating the synchronised bursting that accompanies reflex milk ejection in lactating rats (26) .
Dendritic oxytocin release can be triggered by agents that mobilize calcium from intracellular stores, including oxytocin itself (16) , and can occur without an increase in electrical activity and without oxytocin secretion from nerve terminals (23) . Thus, in some physiological conditions, including suckling, osmotic challenge, and in response to some specific stressors (20) , dendritic release occurs independently of secretion from the nerve terminals.
We recently studied the effect of -melanocyte-stimulating hormone ( -MSH), a peptide produced by neurons in the arcuate nucleus (43) , on SON oxytocin neurons.
Centrally-injected -MSH and oxytocin have similar actions on many behaviors in the rat, and it seems possible that centrally-released oxytocin mediates some of the behavioral effects of centrally-administered -MSH. The melanocortin 4 (MC4) receptor mRNA is expressed abundantly in the SON and PVN (28) , and melanocortin-containing neurons of the arcuate nucleus project directly to the SON (35) . 4 We previously showed that -MSH differentially regulates dendritic and systemic release of oxytocin (34) : central injections of -MSH or MC4 agonists decrease the electrical activity of oxytocin cells and consequently reduce peripheral oxytocin secretion. However, -MSH induces oxytocin release from dendrites in isolated SON, probably as a consequence of its stimulating effect on intracellular calcium stores. In the present study, we investigated the mechanisms by which -MSH inhibits oxytocin cells. Oxytocin, like -MSH, mobilises intracellular calcium stores in oxytocin cells (16) , and triggers presynaptic inhibition of afferent inputs that is mediated by cannabinoids (9) . We therefore hypothesized that the same mechanism might underlie the inhibitory effects of -MSH. To test this, we recorded from oxytocin cells in the SON in vivo, and showed that cannabinoid antagonists applied to the SON by retrodialysis could block the response of oxytocin cells to i.c.v. injection of -MSH. We then went on to compare the effects of cannabinoids and -MSH applied to the SON on the responses of SON neurons to electrical stimulation of an afferent pathway. The pathway chosen for these studies was the projection from the organum vasculosum of the lamina terminalis (OVLT). The OVLT projects directly to the SON both directly and indirectly via the nucleus medianus (24, 18) ; this projection has been well characterised in previous studies, and stimulation of the OVLT evokes a mixed response that has an inhibitory component mediated by GABA and an excitatory component mediated by glutamate (4) .
MATERIALS AND METHODS

Electrophysiology
Experiments were performed on adult female Sprague-Dawley rats anesthetized with urethane (1.25 g/kg i.p.). A femoral vein and trachea were cannulated, and for i.c.v. injections, an injection cannula was implanted into the lateral ventricle (coordinates from bregma: 0.6 mm posterior; 1.6 mm lateral; depth, 4 mm). The pituitary stalk, the left SON, and the OVLT were exposed transpharyngeally, and a microdialysis probe loop was placed onto the ventral surface of the SON (21) 
Data analysis
Responses evoked by OVLT stimulation were initially analysed using Spike2 after. In all cases, the duration of the experimental procedures meant that only one or two cells could be fully tested in any one experiment.
RESULTS
Effect of cannabinoid antagonist on MSH-induced inhibition of oxytocin cells
Although i.c.v. injection of -MSH inhibits oxytocin cells, -MSH induces dendritic release of oxytocin (34) . In vitro, oxytocin presynaptically inhibits excitatory inputs via release of endocannabinoids (9), so we investigated whether - 
Effects of OVLT stimulation on oxytocin and vasopressin cells
Typically, SON neurons responded to single-shock stimulation of the OVLT with a brief inhibition followed by a more prolonged excitation, as reported by others In response to these trains ( Fig. 2 ), 27 cells were excited, with an onset latency of 61 ± 9 ms and duration of 468 ± 28 ms. Two cells were inhibited only (not shown), and 13 were inhibited (latency 12 ± 9 ms, duration 183 ± 16 ms) then excited (latency 230 ± 26 ms and 397 ± 40 ms). The mean onset latency, duration, time to peak response and peak response amplitude of vasopressin cells were very similar to those of oxytocin cells (Fig. 3 ).
In cells that were excited only, the mean response for the 27 cells (16 vasopressin and 11 oxytocin cells) was an additional 1.8 ± 0.2 spikes/train, and the responses were maximal at 220 ± 9 ms ( To test whether the responses to OVLT stimulation were stable over time, we monitored responses during > 90 min of microdialysis with aCSF (Fig. 4) . For all 7 cells tested (vasopressin cells and oxytocin cells), the response to stimulation remained apparently unchanged; initially, the mean excitatory response of these cells was an additional 2.8 ± 0.4 spikes/train, and after 90 min, the response was an additional 2.9 ± 0.4 spikes/train ( Fig. 4C ; mean change 0.05 ± 0.1 spikes/train, no significant difference).
Effects of glutamate and GABA A antagonists on responses to OVLT stimulation
To characterize the neurochemical nature of the responses to OVLT stimulation, we applied glutamate and GABA A receptor antagonists to the SON by microdialysis These results are consistent with the conclusion that the excitatory and inhibitory responses reflect glutamate and GABA inputs acting mainly at AMPA/kainate receptors and GABA A receptors respectively, in agreement with previous studies (4).
Effects of cannabinoids on background firing rate
The effects of the CB1 agonist WIN55,212-2 on background firing rate were tested on 10 vasopressin cells (3 continuously-firing, 7 phasic) and 8 oxytocin cells. In 13 of 17 cells, the excitatory response to stimulation was reduced by > 20%
in the presence of a CB1 agonist; four cells were not affected. Overall, the mean excitatory response was reduced by 0.38 ± 0.09 spikes/train (28 ± 5%, n = 17; Fig. 6B ). The 17 cells include three that initially were inhibited then excited in response to OVLT stimulation. For these three cells, we tested the CB1 agonist in the presence of bicuculline. In this condition, the inhibitory component of the response was abolished, so we could ensure that the reduction of excitation by CB1 agonist was not the result of an increase in inhibition (Fig. 7) . In these three cells, the response in the presence of bicuculline was 1.2 ± 0.7 spikes/train, and in the additional presence of CB1 agonist this was reduced by 0.4 ± 0.08 spikes/train.
Effects of -MSH on the excitatory response of oxytocin cells
We demonstrated above that -MSH-induced inhibition of oxytocin cells is (13) . In the present experiments, although bicuculline blocked the inhibitory response of SON neurons to OVLT stimulation, it had little effect on background firing rate; this is surprising, as about half of the afferent input to SON neurons is thought to be mediated by GABA (39) but we have reported this relative lack of effect in previous experiments (22) . It seems that SON neurons compensate for a progressive diminution of GABA input with an decrease in intrinsic excitability: similar perverse stability of spontaneous activity has been described in other circumstances (e.g., 6), possibly indicating that spontaneous firing rate is strongly buffered by multiple negative-feedback mechanisms, including feedbacks mediated by nitric oxide (38) , adenosine (29, 30) , dynorphin (5), vasopressin (21, 32) , oxytocin (14) , and endocannabinoids (9) as well as intrinsic activity-dependent hyperpolarisation (12) . ] in oxytocin cells (34) , which could lead to production of endocannabinoids.
In SON neurons, dendritic peptide release can either precede (26) or succeed systemic release (20) ; or can occur without systemic release, as during forcedswimming (45) . We showed recently that -MSH, can also differentially regulate dendritic and systemic release of oxytocin as -MSH inhibits the electrical activity of oxytocin cells in vivo and as a consequence systemic release of oxytocin, but induces dendritic release of oxytocin (34) . Oxytocin and -MSH have similar effects on several behaviours in rats, in particular, both suppress feeding (2, 41), and both stimulate female and male sexual behaviour (1) . There are many centrally-projecting oxytocin neurons in the PVN, and these have generally been assumed to govern behavioural effects of oxytocin. However although these neurons synthesise oxytocin, this is unlikely to be their major neurotransmitter product -most centrally projecting peptidergic neurons also synthesise a conventional neurotransmitter which appears to be their main synaptic output. Indeed, large dense-cored vesicles that contain peptides are quite rare in synapses, but they can be released from all parts of neurons; Morris and Pow (27) It appears that -MSH acts as a 'switch' to turn off systemic release of oxytocin and switch on dendritic release, depending on physiological demands. Centrally, both 16 oxytocin and -MSH inhibit feeding and stimulate sexual behaviours, but peripheral secretion of oxytocin stimulates natriuresis in rats (40) , and this appropriately accompanies food intake. Without food intake, natriuresis is inappropriate, hence sexual arousal accompanying inhibition of appetite may require stimulation of central oxytocin release and concurrent inhibition of peripheral release. Nevertheless, oxytocin is released into the circulation at orgasm (11); this release is pulsatile, a pattern ineffective for natriuresis but potently effective for smooth muscle contraction (36) . Analogous pulsatile release during reflex milk ejection in lactating rats requires relative quiescence in the background activity of oxytocin cells (7), so another possibility is that the suppression of background activity by -MSH predisposes oxytocin cells for burst firing during ejaculation. 
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